Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Application of hypoxanthine, hypoxanthine riboside, xanthine, xanthosine or any combination thereof in preparation of medicines for treating tumors

A technology of hypoxanthine and hypoxanthine, applied in the field of medicine, can solve the problems of large side effects, insignificant curative effect, easy to cause drug resistance, etc., and achieve the effect of obvious anti-tumor effect, low toxicity and anti-tumor effect.

Inactive Publication Date: 2016-02-03
崔秀玲
View PDF0 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0010] In view of the defects existing in the above-mentioned prior art, the object of the present invention is to provide a kind of application of hypoxanthine, hypoxanthine, xanthine, xanthoside or any combination thereof in the preparation of drugs for treating tumors, which solves the problem of existing treatment The technical problems of tumor drugs with insignificant curative effect, large side effects, and susceptibility to drug resistance

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of hypoxanthine, hypoxanthine riboside, xanthine, xanthosine or any combination thereof in preparation of medicines for treating tumors
  • Application of hypoxanthine, hypoxanthine riboside, xanthine, xanthosine or any combination thereof in preparation of medicines for treating tumors

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0032] Mix deoxyadenosine, cytidine, hypoxanthine, and inosine evenly according to the mass ratio of 3:1:1:2, and record it as drug 1.

Embodiment 2

[0034] Mix xanthine, inosine, and adenosine evenly according to the mass ratio of 1:3:4, and record it as drug 2.

Embodiment 3

[0036] Mix adenine, xanthosine, and inosine evenly according to the mass ratio of 3:2:5, and record it as drug 3.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention provides application of hypoxanthine, hypoxanthine riboside, xanthine, xanthosine or any combination thereof in preparation of medicines for treating tumors, and belongs to the technical field of medicines. The invention further comprises application of a combination of the hypoxanthine, the hypoxanthine riboside, the xanthine, the xanthosine or any combination of the hypoxanthine, the hypoxanthine riboside, the xanthine and the xanthosine and one or more of a human basic group, nucleoside or deoxynucleoside. The hypoxanthine, the hypoxanthine riboside, the xanthine, the xanthosine or any combination thereof can be applied to chemical treatment of malignant tumors of liver cancer, lung cancer, esophagus cancer, gastric cancer, colon cancer, pancreatic cancer, prostate cancer, leukemia, promyelocytic leukemia, breast cancer, ovarian cancer, cervical cancer or T-cell lymphoma and the like, has an obvious antitumor effect, is free of myelosuppression or an important organ damage at a normal dosage, and has the antitumor effects of high efficiency, broad spectrum and low toxicity.

Description

technical field [0001] The invention relates to the application of hypoxanthine, hypoxanthine, xanthine, xanthoside or any combination thereof in the preparation of drugs for treating tumors, and belongs to the technical field of medicine. Background technique [0002] Tumor is a new organism formed by the body under the action of various tumorigenic factors, and the cells of local tissues lose their normal regulation of their growth at the gene level, resulting in abnormal proliferation and differentiation. Once a new organism is formed, it does not stop growing due to the elimination of the cause. Its growth is not regulated by normal body physiology, but destroys normal tissues and organs. This is especially obvious in malignant tumors. Compared with benign tumors, malignant tumors grow faster and show invasive growth, are prone to bleeding, necrosis, ulcers, etc., and often have distant metastasis, resulting in emaciation, weakness, anemia, loss of appetite, fever, and s...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K31/708A61K31/7076A61K31/522A61P35/00A61P35/02A61K31/7068
Inventor 崔秀玲
Owner 崔秀玲
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products